Lawrence Cohen
Präsident bei BioMedical Marketing Association
Profil
Lawrence Cohen is currently the Director at SenGenix, Inc., President at BioMedical Marketing Association, and Vice President at American Red Cross Raritan Valley Chapter.
Previously, he was the Chief Executive Officer at HemoSense, Inc. from 1998 to 2002, Chief Executive Officer at Meridian Bioscience Israel Ltd., Chief Executive Officer & Director at Glycotest, Inc., and Vice President at Ortho-Clinical Diagnostics, Inc. He was also the President at International Technidyne Corp.
from 2007 to 2010.
Additionally, he was a Member of the National Blood Foundation.
Mr. Cohen received his undergraduate degree from Emporia State University.
Aktive Positionen von Lawrence Cohen
| Unternehmen | Position | Beginn |
|---|---|---|
| BioMedical Marketing Association | Präsident | - |
| American Red Cross Raritan Valley Chapter | Corporate Officer/Principal | - |
SenGenix, Inc.
 SenGenix, Inc. Medical/Nursing ServicesHealth Services SenGenix, Inc. develops point-of-care diagnostic tests (POCT) based on fluorescently responsive sensors. The firm’s FRS-based strips are used to test various types of clinical analytes, including electrolytes, metabolites, drugs, proteins and cells. The company was founded in 2012 and is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Lawrence Cohen
| Unternehmen | Position | Ende |
|---|---|---|
International Technidyne Corp.
 International Technidyne Corp. Medical SpecialtiesHealth Technology International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ. | Präsident | - |
HemoSense, Inc.
 HemoSense, Inc. Medical SpecialtiesHealth Technology HemoSense, Inc. develops and manufactures easy-to-use, handheld blood coagulation systems for use by patients and healthcare professionals in the management of warfarin medication. The company was founded in 1997 and is headquartered in San Jose, CA. | Präsident | 01.04.2002 |
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Vorstandsvorsitzender | - |
| EXALENZ BIOSCIENCE LTD | Vorstandsvorsitzender | - |
| National Blood Foundation | Corporate Officer/Principal | - |
Ausbildung von Lawrence Cohen
| Emporia State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
HemoSense, Inc.
HemoSense, Inc. Medical SpecialtiesHealth Technology HemoSense, Inc. develops and manufactures easy-to-use, handheld blood coagulation systems for use by patients and healthcare professionals in the management of warfarin medication. The company was founded in 1997 and is headquartered in San Jose, CA. | Health Technology |
SenGenix, Inc.
SenGenix, Inc. Medical/Nursing ServicesHealth Services SenGenix, Inc. develops point-of-care diagnostic tests (POCT) based on fluorescently responsive sensors. The firm’s FRS-based strips are used to test various types of clinical analytes, including electrolytes, metabolites, drugs, proteins and cells. The company was founded in 2012 and is headquartered in Durham, NC. | Health Services |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Health Technology |
International Technidyne Corp.
International Technidyne Corp. Medical SpecialtiesHealth Technology International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ. | Health Technology |
| BioMedical Marketing Association | |
| National Blood Foundation | |
Meridian Bioscience Israel Ltd.
 Meridian Bioscience Israel Ltd. Medical SpecialtiesHealth Technology Meridian Bioscience Israel Ltd. engages in the development, manufacturing, marketing, and distribution of diagnostic and life science products. It offers its solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies. The company was founded by Uri Geiger on April 11, 2006 and is headquartered in Modi'in-Maccabim-Re'ut, Israel. | Health Technology |
| American Red Cross Raritan Valley Chapter | |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
